)
Ajinomoto (2802) investor relations material
Ajinomoto Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved record first-quarter sales of ¥412.1 billion (up 13.2% YoY), business profit of ¥60.1 billion (up 27.3% YoY), and profit attributable to owners of ¥36.4 billion (up 13.1% YoY), with all major segments reporting increased sales and profits.
Upward revisions were made to full-year forecasts for sales, business profit, and profit attributable to owners, reflecting robust demand in Functional Materials and Healthcare and Others.
The company is proactively addressing cost increases from Middle East tensions and aims to achieve its revised plan and 2030 Roadmap ahead of schedule.
Announced absorption-type merger of Ajinomoto Fine-Techno Co. into Ajinomoto Inc., effective April 2027, to enhance competitiveness and tax efficiency in Functional Materials.
Continued investment in human resources, marketing, and R&D to support long-term growth.
Financial highlights
Q1 FY2026 sales reached ¥412.1 billion (+13.2% YoY), business profit ¥60.1 billion (+27.3% YoY), and profit attributable to owners ¥36.4 billion (+13.1% YoY); basic EPS was ¥38.11 (+16.8% YoY).
Organic growth rate was 5.7%, business profit growth 27.3%, and EBITDA margin 20.3% for the first quarter.
Total comprehensive income was ¥48.7 billion (+97.5% YoY).
Excluding currency translation, sales and business profit were 105% and 119% of the previous year, respectively.
FY2026 revised forecasts: sales ¥1,732.0 billion (+9.4% YoY), business profit ¥202.0 billion (+11.5% YoY), profit attributable to owners ¥123.5 billion (-8.3% YoY).
Outlook and guidance
Full-year forecast revised upward: sales by ¥9 billion, business profit by ¥5 billion, and profit attributable to owners by ¥3.5 billion, assuming an exchange rate of ¥150/USD.
Middle East conflict expected to increase annual costs by ¥25 billion, with offsetting measures planned.
The company aims to minimize cost impacts through cost reduction and agile pricing.
Strong demand in Functional Materials and CDMO expected to continue, supporting guidance.
Forecasts reflect economic conditions, sales trends, and raw material costs.
- Marketing and digital transformation accelerate growth, ESG progress, and brand value for 2030.2802
Investor update - Global leader in amino acid science targets growth, health impact, and major sustainability gains.2802
Investor presentation - AI-driven growth boosts ABF/ABF™ demand, margins, and capacity through innovation and investment.2802
Investor update - Record profit and sales growth achieved, with further gains targeted amid managed global risks.2802
Q4 2026 - Integrated sustainability and agri-food innovation drive growth and aim to double key solution sales by 2030.2802
Investor Day 2026 - Record sales and profit highs, with raised full-year profit outlook and strong segment momentum.2802
Q3 2026 - Doubling medical food sales by 2030 through 20%+ growth, innovation, and global expansion.2802
Investor update - Sales up 7.7% with record profit, but net profit fell 12% on tax; guidance unchanged.2802
Q1 2025 - Record sales and profit growth led to upward forecasts and increased shareholder returns.2802
Q2 2025
Next Ajinomoto earnings date
Next Ajinomoto earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage